Patient Capital Management’s Illumina ILMN Stock Holding History

Patient Capital Management’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.7M	Sell	345,314 -199,466	-37%	-$29.2M	1.99%	23
2026 Q1	$67.1M	Sell	544,780 -30,988	-5%	-$4.07M	2.46%	20
2025 Q4	$75.5M	Sell	575,768 -5,591	-1%	-$656K	2.91%	15
2025 Q3	$55.2M	Sell	581,359 -831	-0.1%	-$82.4K	2.21%	23
2025 Q2	$55.5M	Buy	582,190 +123,521	+27%	+$10M	2.51%	21
2025 Q1	$36.4M	Buy	458,669 +48,714	+12%	+$5.27M	1.87%	26
2024 Q4	$54.8M	Sell	409,955 -1,600	-0.4%	-$228K	2.53%	23
2024 Q3	$53.7M	Sell	411,555 -3,303	-0.8%	-$407K	2.64%	19
2024 Q2	$43.3M	Buy	414,858 +162,703	+65%	+$18.3M	2.3%	22
2024 Q1	$33.7M	Buy	252,155 +4,738	+2%	+$635K	1.64%	30
2023 Q4	$33.5M	Buy	+247,417	New	+$28.5M	1.78%	29

Other funds holding ILMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Patient Capital Management's ILMN Position: Q2 2026 in Review

Patient Capital Management reduced its Illumina (ILMN) stake by 37% in Q2 2026, selling an estimated $29.2M and leaving 345,314 shares worth $60.7M. The position accounts for 1.99% of the portfolio, ranked #23.

Patient Capital Management first reported a position in ILMN in Q4 2023 and has held it in 11 quarters since. The position peaked at $75.5M in Q4 2025. 939 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

Patient Capital Management held 345,314 shares of Illumina worth $60.7M as of Q2 2026.
Patient Capital Management sold 199,466 Illumina shares in Q2 2026, an estimated $29.2M.
Illumina made up 1.99% of Patient Capital Management's portfolio in Q2 2026, its #23 holding.
Patient Capital Management first reported a position in Illumina in Q4 2023 and has held it in 11 quarters since.
Patient Capital Management's Illumina position peaked at $75.5M in Q4 2025.
939 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on Patient Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.